Taylor Jonathan, Thomas Richard, Metherall Peter, van Gastel Marieke, Cornec-Le Gall Emilie, Caroli Anna, Furlano Monica, Demoulin Nathalie, Devuyst Olivier, Winterbottom Jean, Torra Roser, Perico Norberto, Le Meur Yannick, Schoenherr Sebastian, Forer Lukas, Gansevoort Ron T, Simms Roslyn J, Ong Albert C M
3DLab, Medical Imaging Medical Physics, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Department of Nephrology, University Medical Centre Groningen, Groningen, The Netherlands.
Kidney Int Rep. 2023 Nov 4;9(2):249-256. doi: 10.1016/j.ekir.2023.10.029. eCollection 2024 Feb.
Accurate tools to inform individual prognosis in patients with autosomal dominant polycystic kidney disease (ADPKD) are lacking. Here, we report an artificial intelligence (AI)-generated method for routinely measuring total kidney volume (TKV).
An ensemble U-net algorithm was created using the nnUNet approach. The training and internal cross-validation cohort consisted of all 1.5T magnetic resonance imaging (MRI) data acquired using 5 different MRI scanners (454 kidneys, 227 scans) in the CYSTic consortium, which was first manually segmented by a single human operator. As an independent validation cohort, we utilized 48 sequential clinical MRI scans with reference results of manual segmentation acquired by 6 individual analysts at a single center. The tool was then implemented for clinical use and its performance analyzed.
The training or internal validation cohort was younger (mean age 44.0 vs. 51.5 years) and the female-to-male ratio higher (1.2 vs. 0.94) compared to the clinical validation cohort. The majority of CYSTic patients had mutations (79%) and typical disease (Mayo Imaging class 1, 86%). The median DICE score on the clinical validation data set between the algorithm and human analysts was 0.96 for left and right kidneys with a median TKV error of -1.8%. The time taken to manually segment kidneys in the CYSTic data set was 56 (±28) minutes, whereas manual corrections of the algorithm output took 8.5 (±9.2) minutes per scan.
Our AI-based algorithm demonstrates performance comparable to manual segmentation. Its rapidity and precision in real-world clinical cases demonstrate its suitability for clinical application.
目前缺乏用于告知常染色体显性遗传性多囊肾病(ADPKD)患者个体预后的准确工具。在此,我们报告一种人工智能(AI)生成的常规测量总肾体积(TKV)的方法。
使用nnUNet方法创建了一种集成U-net算法。训练和内部交叉验证队列由CYSTic联盟中使用5种不同MRI扫描仪采集的所有1.5T磁共振成像(MRI)数据组成(454个肾脏,227次扫描),这些数据最初由一名操作人员进行手动分割。作为独立验证队列,我们利用了48例连续的临床MRI扫描,这些扫描具有由单个中心的6名分析人员获得的手动分割参考结果。然后将该工具应用于临床并分析其性能。
与临床验证队列相比,训练或内部验证队列的患者更年轻(平均年龄44.0岁对51.5岁),女性与男性的比例更高(1.2对0.94)。大多数CYSTic患者有突变(79%)和典型疾病(梅奥影像分级1级,86%)。算法与人类分析人员之间在临床验证数据集上,左肾和右肾的中位DICE评分为0.96,TKV中位误差为-1.8%。在CYSTic数据集中手动分割肾脏所需的时间为56(±28)分钟,而对算法输出进行手动校正每次扫描需要8.5(±9.2)分钟。
我们基于AI的算法表现出与手动分割相当的性能。其在实际临床病例中的快速性和精确性表明它适用于临床应用。